ClinicalTrials.Veeva
Menu

Find clinical trials for Colon Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Colonic Cancer
Cancer
Rectal Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma
Lung Cancer

Colon Cancer trials near San Antonio, TX, USA:

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

This study will investigate the safety, tolerability, pharmacokinetics, and anti-tumor activity of CBI-1214 in participants with advanced or...

Enrolling
Colorectal Cancer (CRC)
Colon Cancer
Biological: CBI-1214

Phase 1

Cartography Biosciences

San Antonio, Texas, United States and 3 other locations

is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236
Drug: RMC-9805

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 16 other locations

This first-in-human study will evaluate safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of ....

Enrolling
Advanced Cancer
Advanced Solid Tumors
Drug: PHN-012

Phase 1

Pheon Therapeutics

San Antonio, Texas, United States and 6 other locations

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors....

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236

Phase 1, Phase 2

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 15 other locations

The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer...

Enrolling
Metastatic Breast Cancer (HR+/ HER2-)
Triple Negative Breast Cancer
Drug: Cetuximab
Drug: PF-08032562

Phase 1

Pfizer
Pfizer

San Antonio, Texas, United States of America and 2 other locations

dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chondrosarcoma, an...

Active, not recruiting
Any Solid Tumor
Glioma
Drug: LY3410738
Drug: Gemcitabine

Phase 1

Lilly
Lilly

San Antonio, Texas, United States of America and 32 other locations

tolerability, and PK profiles of Elironrasib and Daraxonrasib as monotherapies and combination therapy in patients with KRAS G12C-mutated solid tumors...

Enrolling
Non-Small Cell Lung Cancer (NSCLC)
Colorectal Cancer
Drug: Elironrasib
Drug: Daraxonrasib

Phase 1, Phase 2

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 52 other locations

The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutation...

Enrolling
Advanced Solid Tumors
CRC (Colorectal Cancer)
Drug: cetuximab
Drug: ALTA3263

Phase 1

Alterome Therapeutics, Inc.

San Antonio, Texas, United States and 8 other locations

This is a study to evaluate the safety and potential anti-tumor activity of an investigational agent called ARV-806 in Adults with Advanced ...

Enrolling
Advanced Solid Cancer
KRAS G12D Mutation
Drug: ARV-806

Phase 1, Phase 2

Arvinas
Arvinas

San Antonio, Texas, United States and 13 other locations

to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combinatio...

Active, not recruiting
Advanced Solid Tumor
Non-small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Irinotecan

Phase 1

Lilly
Lilly

San Antonio, Texas, United States of America and 57 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems